Drawing for GRIDION

USPTO serial 79102480

GRIDION

Reviewed by CopyMark Law Group

Reg. 4452830Status 706Registered
Filing date
Status date
Registration date
Dec 24, 2013
Examiner
PEREZ, STEVEN M
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with GRIDION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210-2206United States

Goods and services

ClassDescriptionStatusFirst use
009Apparatus and instruments for biological, chemical, biochemical, DNA, RNA, [ protein, ] polynucleic acid sequencing and molecular analysis, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICs ( application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis; apparatus and instruments for use in laboratory analysis, namely, test sample cartridges; computer programs, computer hardware and data processing apparatus, all for analysis, processing and recording of scientific data and analyte information; silicon chips; DNA chips; microarray chips; analyte detector chips; biosensor chips; parts and fittings for automated instruments for detecting the presence, properties and identity of analytes, namely, test sample cartridgesACTIVE
010blood testing apparatus; testing apparatus for medical or veterinary purposes, namely, tissue testing apparatus for pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system and cardiovascular diseasesACTIVE
042Scientific and technological services and research and design relating thereto, namely, consultation, research and design services relating to automated systems and instruments for direct electrical detection and analysis of molecules for use in the field of genomics, [ protein analysis, ] molecular analysis, life sciences, healthcare, security and defence; industrial analysis and research services in the field of genomics, [ protein analysis, ] molecular analysis, life sciences, healthcare, security and defence; biological, chemical, biochemical, DNA, RNA, [ protein, ] polynucleic acid and molecular analysis services, namely, DNA and RNA and polynucleic acid sequences services, [ protein ] sequencing services, genome sequencing services; design and development of instruments and apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; laboratory testing services; DNA and polynucleic acid testing services; information and advice regarding all the aforesaid servicesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 19, 2026INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Sep 10, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 31, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 31, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Dec 31, 202471AGREGISTERED-SEC.71 ACCEPTED
Dec 30, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 31, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
May 24, 2024ES71TEAS SECTION 71 RECEIVED
Mar 22, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 24, 2022REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Dec 4, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED
Sep 25, 2021INNPPARTIAL INVALIDATION PROCESSED BY THE IB
Aug 5, 2021RNWLINTERNATIONAL REGISTRATION RENEWED
Aug 3, 2021INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 3, 2021INPCINVALIDATION PROCESSED
Jul 25, 2021INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 25, 2020NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Nov 25, 202071AGREGISTERED-SEC.71 ACCEPTED
Nov 16, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 16, 2020ES71TEAS SECTION 71 RECEIVED
Nov 1, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED
Dec 24, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 13, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 13, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 11, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED
Jun 6, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB
May 21, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB
May 21, 2014FIMPFINAL DISPOSITION PROCESSED
Mar 24, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 24, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 1, 2013GPNXNOTIFICATION PROCESSED BY IB
Oct 8, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 18, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 18, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 18, 2013NPUBNOTICE OF PUBLICATION
Sep 5, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 5, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 23, 2013OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 21, 2013RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 13, 2013ALIEASSIGNED TO LIE
Mar 6, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 6, 2013OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 11, 2012CNSLLETTER OF SUSPENSION MAILED
Sep 10, 2012CNSLSUSPENSION LETTER WRITTEN
Aug 13, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 13, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 13, 2012ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 5, 2012CNSLLETTER OF SUSPENSION MAILED
Jun 5, 2012CNSLSUSPENSION LETTER WRITTEN
May 14, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 5, 2011RFNTREFUSAL PROCESSED BY IB
Nov 17, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 17, 2011RFRRREFUSAL PROCESSED BY MPU
Nov 17, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 16, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2011DOCKASSIGNED TO EXAMINER
Oct 8, 2011MAFRAPPLICATION FILING RECEIPT MAILED
Oct 4, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance